Multiomics for 5P medicine

Описание: Alice Limonciel, Ph.D.
Chief Scientific Officer
biocrates life sciences gmbh | Austria

Part of the webinar
5P medicine | Transform neurology and oncology with metabolomics

Title
Multiomics for 5P medicine

Abstract
Metabolomics technologies have matured over the last 20 years to provide broad and robust pictures of a person’s biology. Combined with an appropriate study design, metabolomics can reveal mechanisms and complex biomarkers that will enable a new generation of care. Thanks to the development of standardized metabolomics, the implementation of this tool in routine diagnostic and prognostic procedures is at our fingertips. Metabolomics also integrates very well with other omics (genomics, epigenomics, proteomics, microbiome…) in multiomics data analysis, providing powerful tools for personalized medicine and population health applications. In this talk, Dr. Alice Limonciel, the chief scientific officer of biocrates, will discuss how metabolomics is leveraged in today’s biomedical research, and the added value of including metabolomics in a multiomics approach.

www.biocrates.com